Exclusive news this morning: IBM is halting sales of its Watson AI tool to help pharma companies discover new drugs. The co’s struggle reveals the difficulty of scaling AI in medicine via
IBM is halting development and sales of its Watson artificial intelligence software to help pharmaceutical companies discover new treatments.
What is happening with Watson's other endeavors? Friends want to know.
Maybe the only group more incompetent than our President trying to collude is IBM trying to build anything that works.
After the “Watson for Hospitals” fiasco, IBM is now shutting down the “Watson for Pharma” division. I told them these would fail in 2013, but did they listen? My suggestion of targeting Watson to insurers and regulators was too small a market for them.
IBM halting sales of Watson AI tool for drug discovery
IBM is halting development and sales of a product that uses its Watson #artificialintelligence software to help pharmaceutical companies discover new drugs.
IBM halting sales of Watson AI tool for drug discovery
IBM is halting development and sales of a product that uses its Watson #ArtificialIntelligence software to help pharmaceutical companies discover new drugs.
IBM halting sales of Watson AI tool for drug discovery.
IBM is halting sales of #Watson AI tool for drug discovery amid sluggish growth … #artificialintelligence #pharma #ibmwatson #ibm
IBM halting sales of Watson AI tool for drug discovery - STAT
zombie AI laid to rest IBM halting sales of Watson AI tool for drug discovery amid sluggish growth via
Turns out health care, cancer treatment decisions, and drug development can *all* be pretty complicated via